Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83eacfb21bcbdd6603a8e3fc7010d01d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e7fe5706d8518e423c5c61d0d38757b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-22 |
filingDate |
2006-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d6301e88f230567b1c887507a16dace http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c39ac00e13fa93172390eadbaeb02af |
publicationDate |
2010-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2010041724-A1 |
titleOfInvention |
Process For Synthesizing A CETP Inhibitor |
abstract |
An efficient process is disclosed for producing a compound that is an inhibitor of CETP. The last step of the process is the coupling of an oxazolidinone derivative with a biphenyl moiety to provide a compound of formula (I). In a specific embodiment of this synthesis, a crystalline product is produced which is characterized as a non-solvated crystalline polymorph. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016067194-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8486983-B2 |
priorityDate |
2005-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |